{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:19:49Z","timestamp":1787746789377,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00101-026-01709-8","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:40:38Z","timestamp":1784713238000},"page":"667-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heredit\u00e4re H\u00e4mostasest\u00f6rungen in der Geburtshilfe 2\/2\u00a0\u2013 an\u00e4sthesiologische Aspekte der sekund\u00e4ren H\u00e4mostase","Hereditary disorders of hemostasis in obstetrics 2\/2\u2014Anesthesiological aspects of secondary hemostasis"],"prefix":"10.1007","volume":"75","author":[{"given":"F.","family":"Fette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koscielny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-L.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"1709_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-026-01710-1","author":"F Fette","year":"2026","unstructured":"Fette\u00a0F, Roll\u00a0F, Kranke\u00a0P et\u00a0al (2026) Heredit\u00e4re H\u00e4mostasest\u00f6rungen in der Geburtshilfe 1\/2 \u2013 An\u00e4sthesiologische Aspekte der H\u00e4mostase. Anaesthesiologie. https:\/\/doi.org\/10.1007\/s00101-026-01710-1","journal-title":"Anaesthesiologie"},{"issue":"4","key":"1709_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1056\/NEJMe2414209","volume":"392","author":"DJ Angiolillo","year":"2025","unstructured":"Angiolillo\u00a0DJ, Capodanno\u00a0D (2025) Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI. N Engl J Med 392(4):400\u2013403. https:\/\/doi.org\/10.1056\/NEJMe2414209","journal-title":"N Engl J Med"},{"issue":"21","key":"1709_CR3","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMra1601561","volume":"375","author":"FW Leebeek","year":"2016","unstructured":"Leebeek\u00a0FW, Eikenboom\u00a0JC (2016) Von Willebrand\u2019s Disease. N Engl J Med 375(21):2067\u20132080. https:\/\/doi.org\/10.1056\/NEJMra1601561","journal-title":"N Engl J Med"},{"issue":"2","key":"1709_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1055\/s-0037-1613195","volume":"88","author":"NB de Bosch","year":"2002","unstructured":"de Bosch\u00a0NB, Mosesson\u00a0MW, Ruiz-Saez\u00a0A, Echenagucia\u00a0M, Rodriguez-Lemoin\u00a0A (2002) Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost 88(2):253\u2013258","journal-title":"Thromb Haemost"},{"issue":"6","key":"1709_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1182\/bloodadvances.2023012186","volume":"8","author":"S Mohsenian","year":"2024","unstructured":"Mohsenian\u00a0S, Palla\u00a0R, Menegatti\u00a0M, Cairo\u00a0A, Lecchi\u00a0A, Casini\u00a0A, Neerman-Arbez\u00a0M, Asselta\u00a0R, Scardo\u00a0S, Siboni\u00a0SM, Blatny\u00a0J, Zapletal\u00a0O, Schved\u00a0JF, Giansily-Blaizot\u00a0M, Halimeh\u00a0S, Daoud\u00a0MA, Platokouki\u00a0H, Pergantou\u00a0H, Schutgens\u00a0REG, Peyvandi\u00a0F et\u00a0al (2024) Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database. Blood Adv 8(6):1392\u20131404. https:\/\/doi.org\/10.1182\/bloodadvances.2023012186","journal-title":"Blood Adv"},{"issue":"8","key":"1709_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1182\/blood.2024025712","volume":"145","author":"A Casini","year":"2025","unstructured":"Casini\u00a0A (2025) How I treat quantitative fibrinogen disorders. Blood 145(8):801\u2013810. https:\/\/doi.org\/10.1182\/blood.2024025712","journal-title":"Blood"},{"issue":"8","key":"1709_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.jtha.2023.04.035","volume":"21","author":"J Hugon-Rodin","year":"2023","unstructured":"Hugon-Rodin\u00a0J, Carriere\u00a0C, Claeyssens\u00a0S, Trillot\u00a0N, Drillaud\u00a0N, Biron-Andreani\u00a0C, Lavenu-Bombled\u00a0C, Wieland\u00a0A, Flaujac\u00a0C, Stieltjes\u00a0N, Lebreton\u00a0A, Brungs\u00a0T, Hegglin\u00a0A, Fiore\u00a0M, Desconclois\u00a0C, Gay\u00a0V, Tardy-Poncet\u00a0B, Beurrier\u00a0P, Barbay\u00a0V, Casini\u00a0A et\u00a0al (2023) Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study. J\u00a0Thromb Haemost 21(8):2126\u20132136. https:\/\/doi.org\/10.1016\/j.jtha.2023.04.035","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1709_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjh.13058","volume":"167","author":"AD Mumford","year":"2014","unstructured":"Mumford\u00a0AD, Ackroyd\u00a0S, Alikhan\u00a0R, Bowles\u00a0L, Chowdary\u00a0P, Grainger\u00a0J, Mainwaring\u00a0J, Mathias\u00a0M, O\u2019Connell\u00a0N, Committee, B (2014) Guideline for the diagnosis and management of the rare coagulation disorders: a\u00a0United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology. EJHaem 167(3):304\u2013326. https:\/\/doi.org\/10.1111\/bjh.13058","journal-title":"Br J Haematol"},{"issue":"7","key":"1709_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/1076029616670257","volume":"23","author":"PO Sevenet","year":"2017","unstructured":"Sevenet\u00a0PO, Kaczor\u00a0DA, Depasse\u00a0F (2017) Factor\u00a0VII Deficiency: From Basics to Clinical Laboratory Diagnosis and Patient Management. Clin Appl Thromb Hemost 23(7):703\u2013710. https:\/\/doi.org\/10.1177\/1076029616670257","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"1709_CR10","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/bjh.70056","volume":"207","author":"KHG Rutten","year":"2025","unstructured":"Rutten\u00a0KHG, Tsiamita\u00a0O, Van Thillo\u00a0Q, Raheja\u00a0P, Kaler\u00a0M, van Galen\u00a0KPM, Hogg\u00a0M, Bowles\u00a0L, Schutgens\u00a0REG, Sivapalaratnam\u00a0S (2025) Management of pregnancy and childbirth in Glanzmann thrombasthenia: A case series and review. EJHaem 207(4):1702\u20131708. https:\/\/doi.org\/10.1111\/bjh.70056","journal-title":"Br J Haematol"},{"issue":"12","key":"1709_CR11","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1111\/jth.15872","volume":"20","author":"R Abdul-Kadir","year":"2022","unstructured":"Abdul-Kadir\u00a0R, Gomez\u00a0K (2022) Reproductive health and hemostatic issues in women and girls with congenital factor\u00a0VII deficiency: A\u00a0systematic review. J\u00a0Thromb Haemost 20(12):2758\u20132772. https:\/\/doi.org\/10.1111\/jth.15872","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1709_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2024.2332794","volume":"37","author":"D Surbek","year":"2024","unstructured":"Surbek\u00a0D, Blatny\u00a0J, Wielgos\u00a0M, Acs\u00a0N, Edwards\u00a0H, Erez\u00a0O, Bartha\u00a0JL, Madar\u00a0H, Mercier\u00a0FJ, Schlembach\u00a0D, Di Renzo\u00a0GC (2024) Role of recombinant factor VIIa in the clinical management of severe postpartum hemorrhage: consensus among European experts. J\u00a0Matern Fetal Neonatal Med 37(1):2332794. https:\/\/doi.org\/10.1080\/14767058.2024.2332794","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"1709_CR13","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s00277-023-05287-2","volume":"103","author":"M Shima","year":"2024","unstructured":"Shima\u00a0M (2024) Current status and future prospects of activated recombinant coagulation factor\u00a0VIIa, NovoSeven(R), in the treatment of haemophilia and rare bleeding disorders. Hematol Cell Ther 103(8):2647\u20132658. https:\/\/doi.org\/10.1007\/s00277-023-05287-2","journal-title":"Ann Hematol"},{"issue":"17","key":"1709_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191710918","volume":"19","author":"A Krzyzanowski","year":"2022","unstructured":"Krzyzanowski\u00a0A, Geca\u00a0T, Sokolowska\u00a0B, Kwiatek\u00a0M, Miturski\u00a0A, Stupak\u00a0A, Terlecki\u00a0P, Paluszkiewicz\u00a0P, Kwasniewska\u00a0A (2022) Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a\u00a0Pregnant Woman with Severe Hypoproconvertinemia\u2011A Case Series and Review of the Literature. Int J Environ Res Public Health 19(17):10918. https:\/\/doi.org\/10.3390\/ijerph191710918","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"1709_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/rapm-2024-105674","volume":"50","author":"B Hyers","year":"2025","unstructured":"Hyers\u00a0B, Cabrera\u00a0C, Walsh\u00a0C, Reddy\u00a0A, Strulowitz\u00a0T, Hamburger\u00a0J, Knibbs\u00a0N, Katz\u00a0D, Ferrara\u00a0L, Beilin\u00a0Y (2025) Anesthetic management with labor epidural analgesia of the parturient with severe factor VII deficiency: a case report. Reg Anesth Pain Med 50(9):764\u2013767. https:\/\/doi.org\/10.1136\/rapm-2024-105674","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"1709_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ajh.27602","volume":"100","author":"D Jiang","year":"2025","unstructured":"Jiang\u00a0D, Wang\u00a0M, Wheeler\u00a0AP, Croteau\u00a0SE (2025) 2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders. Am J Hematol 100(4):666\u2013684. https:\/\/doi.org\/10.1002\/ajh.27602","journal-title":"Am J Hematol"},{"issue":"10480","key":"1709_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(24)02139-1","volume":"405","author":"P Chowdary","year":"2025","unstructured":"Chowdary\u00a0P, Carcao\u00a0M, Kenet\u00a0G, Pipe\u00a0SW (2025) Haemophilia. Lancet 405(10480):736\u2013750. https:\/\/doi.org\/10.1016\/S0140-6736(24)02139-1","journal-title":"Lancet"},{"issue":"6","key":"1709_CR18","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jtha.2025.02.031","volume":"23","author":"S Desage","year":"2025","unstructured":"Desage\u00a0S, Lienhart\u00a0A, Janbain\u00a0M, Rezigue\u00a0H, Leuci\u00a0A, Dargaud\u00a0Y (2025) Discrepancy between one-stage clotting and chromogenic factor\u00a0VIII activity in women with hemophilia A and hemophilia A carriers: a\u00a0retrospective clinical study. J\u00a0Thromb Haemost 23(6):1817\u20131823. https:\/\/doi.org\/10.1016\/j.jtha.2025.02.031","journal-title":"J Thromb Haemost"},{"key":"1709_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2026.01.015","author":"PH Cygan","year":"2026","unstructured":"Cygan\u00a0PH, Weidman\u00a0EA, Wang\u00a0X, Kong\u00a0L, Eyster\u00a0ME, Carrel\u00a0L (2026) Integrative modeling to improve bleeding risk prediction in adult female hemophilia A carriers. J\u00a0Thromb Haemost. https:\/\/doi.org\/10.1016\/j.jtha.2026.01.015","journal-title":"J Thromb Haemost"},{"issue":"16","key":"1709_CR20","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1182\/blood.2025029829","volume":"146","author":"B Guillet","year":"2025","unstructured":"Guillet\u00a0B, d\u2019 Oiron\u00a0R, Trossaert\u00a0M, Wibaut\u00a0B, Pan-Petesch\u00a0B, Frotscher\u00a0B, Volot\u00a0F, Ardillon\u00a0L, Desage\u00a0S, Falaise\u00a0C, Biron-Andreani\u00a0C, Cussac\u00a0V, Tardy\u00a0B, Huguenin\u00a0Y, Chambost\u00a0H, Bayart\u00a0S, Castet\u00a0SM, Delavenne\u00a0X (2025) F8 gene variants influence the response to desmopressin in hemophilia A carriers. Blood 146(16):1991\u20132004. https:\/\/doi.org\/10.1182\/blood.2025029829","journal-title":"Blood"},{"issue":"5","key":"1709_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/hae.70097","volume":"31","author":"S Linari","year":"2025","unstructured":"Linari\u00a0S, Pollio\u00a0B, Ferretti\u00a0A, Napolitano\u00a0M, Grandone\u00a0E, Siboni\u00a0S, Aru\u00a0AB, Bertoni\u00a0E, Biasoli\u00a0C, Cantori\u00a0I, Di Gregorio\u00a0P, Lassandro\u00a0G, Sottilotta\u00a0G, Strangio\u00a0A, Villa\u00a0MR, Castaman\u00a0G, Rocino\u00a0A, Italian Association of Hemophilia Centers, M. E. C. d. W. G. (2025) Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B. Haemophilia 31(5):1015\u20131024. https:\/\/doi.org\/10.1111\/hae.70097","journal-title":"Haemophilia"},{"key":"1709_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2026.02.031","author":"A de Vaan","year":"2026","unstructured":"de Vaan\u00a0A, Kruip\u00a0M, Eikenboom\u00a0J, Punt\u00a0MC, Coppens\u00a0M, Nieuwenhuizen\u00a0L, Schols\u00a0SEM, Makelburg\u00a0A, Heubel-Moenen\u00a0F, Duvekot\u00a0JJ, Peters\u00a0M, Middeldorp\u00a0JM, Bloemenkamp\u00a0K, Schutgens\u00a0R, Lely\u00a0AT, van Galen\u00a0K (2026) Enhanced Peripartum Hemostatic Management Does Not Decrease Postpartum Hemorrhage Incidence in Hemophilia Carriers: the Pregnancy and Inherited Bleeding Disorders study (PRIDES). J\u00a0Thromb Haemost. https:\/\/doi.org\/10.1016\/j.jtha.2026.02.031","journal-title":"J Thromb Haemost"},{"key":"1709_CR23","volume-title":"GeneReviews((R))","author":"BA Konkle","year":"1993","unstructured":"Konkle\u00a0BA, Nakaya Fletcher\u00a0S (1993) Hemophilia A. In: Adam\u00a0MP, Bick\u00a0S, Mirzaa\u00a0GM, Pagon\u00a0RA, Wallace\u00a0SE, Amemiya\u00a0A (Hrsg) GeneReviews((R))"},{"key":"1709_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2026.01.029","author":"C Kelly","year":"2026","unstructured":"Kelly\u00a0C, Cleary\u00a0J, Keenan\u00a0C, Delachapelle\u00a0I, Connolly\u00a0L, Byrne\u00a0M, O\u2019Donovan\u00a0M, O\u2019Connell\u00a0NM, O\u2019Donnell\u00a0JS, Ryan\u00a0K, Lavin\u00a0M (2026) Contrary to current guidance, antenatal factor\u00a0IX levels increase in female carriers of hemophilia B. J\u00a0Thromb Haemost. https:\/\/doi.org\/10.1016\/j.jtha.2026.01.029","journal-title":"J Thromb Haemost"},{"issue":"1S","key":"1709_CR25","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/MBC.0000000000000989","volume":"31","author":"M Falcon Rodriguez","year":"2020","unstructured":"Falcon Rodriguez\u00a0M (2020) Carriers of haemophilia: pregnancy, childbirth and postpartum. Blood Coagul Fibrinolysis 31(1S):S9\u2013S11. https:\/\/doi.org\/10.1097\/MBC.0000000000000989","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"1709_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/ejh.13930","volume":"110","author":"A Mohinani","year":"2023","unstructured":"Mohinani\u00a0A, Patel\u00a0S, Tan\u00a0V, Kartika\u00a0T, Olson\u00a0S, DeLoughery\u00a0TG, Shatzel\u00a0J (2023) Desmopressin as a hemostatic and blood sparing agent in bleeding disorders. Eur J Haematol 110(5):470\u2013479. https:\/\/doi.org\/10.1111\/ejh.13930","journal-title":"Eur J Haematol"},{"issue":"1","key":"1709_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0043-1761217","volume":"50","author":"A Dorgalaleh","year":"2024","unstructured":"Dorgalaleh\u00a0A (2024) The History of Factor\u00a0XIII Deficiency. Semin Thromb Hemost 50(1):34\u201342. https:\/\/doi.org\/10.1055\/s-0043-1761217","journal-title":"Semin Thromb Hemost"},{"key":"1709_CR28","unstructured":"Mangla, A., Hamad, H., Killeen, R. B., & Kumar, A. (2026). Factor\u00a0XIII Deficiency. In StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32491399"},{"issue":"3","key":"1709_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MBC.0000000000000029","volume":"25","author":"JE Odame","year":"2014","unstructured":"Odame\u00a0JE, Chan\u00a0AK, Wu\u00a0JK, Breakey\u00a0VR (2014) Factor\u00a0XIII deficiency management: a\u00a0review of the literature. Blood Coagul Fibrinolysis 25(3):199\u2013205. https:\/\/doi.org\/10.1097\/MBC.0000000000000029","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"1709_CR30","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1111\/hae.12345","volume":"20","author":"LT Sharief","year":"2014","unstructured":"Sharief\u00a0LT, Lawrie\u00a0AS, Mackie\u00a0IJ, Smith\u00a0C, Peyvandi\u00a0F, Kadir\u00a0RA (2014) Changes in factor\u00a0XIII level during pregnancy. Haemophilia 20(2):e144\u2013148. https:\/\/doi.org\/10.1111\/hae.12345","journal-title":"Haemophilia"},{"issue":"4","key":"1709_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ajh.70181","volume":"101","author":"JW Jacobs","year":"2026","unstructured":"Jacobs\u00a0JW, Abels\u00a0EA, Adkins\u00a0BD, Booth\u00a0GS, Costa\u00a0V, Raza\u00a0S, Simon\u00a0M, Woo\u00a0JS, Wheeler\u00a0AP (2026) Factor XIII Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical Implementation. Am J Hematol 101(4):794\u2013806. https:\/\/doi.org\/10.1002\/ajh.70181","journal-title":"Am J Hematol"},{"key":"1709_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.thromres.2020.04.010","volume":"191","author":"L Rugeri","year":"2020","unstructured":"Rugeri\u00a0L, Martinaud\u00a0C, Beurrier\u00a0P, Borg\u00a0Y, Chambost\u00a0H, Chirila-Hetsch\u00a0M, Desprez\u00a0D, Harroche\u00a0A, Milien\u00a0V, Pan-Petesch\u00a0B, Meunier\u00a0S (2020) Gynecological and obstetric outcome in the French cohort of women with factor\u00a0XIII deficiency. Thromb Res 191:22\u201325. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.010","journal-title":"Thromb Res"},{"issue":"2","key":"1709_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.16133","volume":"188","author":"S Bouttefroy","year":"2020","unstructured":"Bouttefroy\u00a0S, Meunier\u00a0S, Milien\u00a0V, Boucekine\u00a0M, Chamouni\u00a0P, Desprez\u00a0D, Harroche\u00a0A, Hochart\u00a0A, Thiercelin-Legrand\u00a0MF, Wibaut\u00a0B, Chambost\u00a0H, Rugeri\u00a0L, CoDe\u00a0C, s.g (2020) Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort. EJHaem 188(2):317\u2013320. https:\/\/doi.org\/10.1111\/bjh.16133","journal-title":"Br J Haematol"},{"issue":"6","key":"1709_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/ejh.13941","volume":"110","author":"M Trossaert","year":"2023","unstructured":"Trossaert\u00a0M, Chamouard\u00a0V, Biron-Andreani\u00a0C, Casini\u00a0A, De Mazancourt\u00a0P, De Raucourt\u00a0E, Drillaud\u00a0N, Frotscher\u00a0B, Guillet\u00a0B, Lebreton\u00a0A, Roussel-Robert\u00a0V, Rugeri\u00a0L, Dargaud\u00a0Y (2023) Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders. Eur J Haematol 110(6):584\u2013601. https:\/\/doi.org\/10.1111\/ejh.13941","journal-title":"Eur J Haematol"},{"key":"1709_CR35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-059276","author":"J Anderst","year":"2022","unstructured":"Anderst\u00a0J, Carpenter\u00a0SL, Abshire\u00a0TC, Killough\u00a0E, Aap Section On Hematology\/Oncology, T. A. S. O. P. H. O. T. A. C. O. C. A., Neglect, Consultants, Mendonca\u00a0EA, Downs\u00a0SM, Section on Hematology\/Oncology executive, c., Wetmore\u00a0C, Allen\u00a0C, Dickens\u00a0D, Harper\u00a0J, Rogers\u00a0ZR, Jain\u00a0J, Warwick\u00a0A, Yates\u00a0A, past executive committee, m., Hooker\u00a0R et\u00a0al (2022) Evaluation for Bleeding Disorders in Suspected Child Abuse. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2022-059276","journal-title":"Pediatrics"},{"issue":"2","key":"1709_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamapediatrics.2019.5040","volume":"174","author":"C Borzutzky","year":"2020","unstructured":"Borzutzky\u00a0C, Jaffray\u00a0J (2020) Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents. JAMA Pediatr 174(2):186\u2013194. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.5040","journal-title":"JAMA Pediatr"},{"issue":"2","key":"1709_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1213\/ane.0b013e3181ac13d1","volume":"109","author":"S Choi","year":"2009","unstructured":"Choi\u00a0S, Brull\u00a0R (2009) Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses. A A Pract 109(2):648\u2013660. https:\/\/doi.org\/10.1213\/ane.0b013e3181ac13d1","journal-title":"Anesth Analg"},{"issue":"6","key":"1709_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2044.2010.06324.x","volume":"65","author":"AA Hanke","year":"2010","unstructured":"Hanke\u00a0AA, Elsner\u00a0O, Gorlinger\u00a0K (2010) Spinal anaesthesia and caesarean section in a patient with hypofibrinogenaemia and factor XIII deficiency. Anaesthesia 65(6):641\u2013645. https:\/\/doi.org\/10.1111\/j.1365-2044.2010.06324.x","journal-title":"Anaesthesia"},{"issue":"5","key":"1709_CR39","first-page":"504","volume":"110","author":"PR Hughes","year":"2024","unstructured":"Hughes\u00a0PR, Lewis\u00a0MN, Adams\u00a0SS (2024) Bleeding and Bruising: Primary Care Evaluation. Am Fam Physician 110(5):504\u2013514","journal-title":"Am Fam Physician"},{"issue":"6","key":"1709_CR40","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.pcl.2013.09.002","volume":"60","author":"R Kumar","year":"2013","unstructured":"Kumar\u00a0R, Carcao\u00a0M (2013) Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond. Pediatr Clin North Am 60(6):1419\u20131441. https:\/\/doi.org\/10.1016\/j.pcl.2013.09.002","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"1709_CR41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/j.1537-2995.2012.03865.x","volume":"53","author":"JH Levy","year":"2013","unstructured":"Levy\u00a0JH, Greenberg\u00a0C (2013) Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 53(5):1120\u20131131. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03865.x","journal-title":"Transfusion"},{"issue":"25","key":"1709_CR42","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.1080\/14767058.2022.2051699","volume":"35","author":"HI Lim","year":"2022","unstructured":"Lim\u00a0HI, DeSancho\u00a0MT (2022) Management and outcomes of mild hemophiliacs and hemophilia carriers during pregnancy and peripartum period: a hemophilia treatment center experience in the United States. J\u00a0Matern Fetal Neonatal Med 35(25):9759\u20139764. https:\/\/doi.org\/10.1080\/14767058.2022.2051699","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"1709_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","volume":"133","author":"M Menegatti","year":"2019","unstructured":"Menegatti\u00a0M, Peyvandi\u00a0F (2019) Treatment of rare factor deficiencies other than hemophilia. Blood 133(5):415\u2013424. https:\/\/doi.org\/10.1182\/blood-2018-06-820738","journal-title":"Blood"},{"issue":"6","key":"1709_CR44","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jtha.2025.01.019","volume":"23","author":"W Peterson","year":"2025","unstructured":"Peterson\u00a0W, Martin\u00a0R, Arnold\u00a0D, Carvalho\u00a0B, Cuker\u00a0A, Gadsden\u00a0J, Provan\u00a0D, Rydz\u00a0N, Shore\u00a0E, Kuter\u00a0D, Kouides\u00a0P, Lavin\u00a0M, James\u00a0P, Engen\u00a0D, Sholzberg\u00a0M (2025) Delphi consensus recommendations for neuraxial anesthesia in adults with platelet disorders and coagulation defects: communication from the ISTH SSC Subcommittee on von Willebrand Factor. J\u00a0Thromb Haemost 23(6):2039\u20132049. https:\/\/doi.org\/10.1016\/j.jtha.2025.01.019","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1709_CR45","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","volume":"10","author":"F Peyvandi","year":"2012","unstructured":"Peyvandi\u00a0F, Palla\u00a0R, Menegatti\u00a0M, Siboni\u00a0SM, Halimeh\u00a0S, Faeser\u00a0B, Pergantou\u00a0H, Platokouki\u00a0H, Giangrande\u00a0P, Peerlinck\u00a0K, Celkan\u00a0T, Ozdemir\u00a0N, Bidlingmaier\u00a0C, Ingerslev\u00a0J, Giansily-Blaizot\u00a0M, Schved\u00a0JF, Gilmore\u00a0R, Gadisseur\u00a0A, Benedik-Dolnicar\u00a0M, European Network of Rare Bleeding Disorders\u00a0G et\u00a0al (2012) Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J\u00a0Thromb Haemost 10(4):615\u2013621. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04653.x","journal-title":"J Thromb Haemost"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-026-01709-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-026-01709-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-026-01709-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:30:21Z","timestamp":1787743821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-026-01709-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1007\/s00101-026-01709-8","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Kranke\n                      : A.\u00a0Finanzielle Interessen: Verg\u00fctung f\u00fcr Vortr\u00e4ge und Weiterbildungsaktivit\u00e4ten f\u00fcr Fresenius Kabi, CSL Vifor, Senzyme, CSL Behring, Pharmacosmos, Livanova, Baxter, Pajunk, Ferring sowie Gr\u00fcnenthal. \u2013\u00a0Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: Baxter.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Klinik und Poliklinik f\u00fcr An\u00e4sthesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie | Universit\u00e4tsklinikum W\u00fcrzburg, Oberd\u00fcrrbacher Str. 6, 97080 W\u00fcrzburg | Mitgliedschaften: DGAI, ESAIC, GT\u00dcM | 1.\u00a0Sprecher des AK Geburtshilfliche An\u00e4sthesie der DGAI.\n                      C.\u00a0Weber\n                      : A.\u00a0Finanzielle Interessen: Vortragshonorare und Reisekostenerstattung von den Firmen: AstraZeneca, CSL, enicor, Haemonetics, LEO, Novo Nordisk, Werfen. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter An\u00e4sthesist, Chefarzt, Sch\u00f6n Klinik Hamburg Eilbeck | Mitgliedschaften: BDA, DGAI, GTH, IAKH, DIVI, ESAIC.\n                      F.\u00a0Fette\n                      : A.\u00a0Finanzielle Interessen: F.\u00a0Fette gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenz\u00e4rztin Asklepios Klinik Wandsbek.\n                      F.\u00a0Roll\n                      : A.\u00a0Finanzielle Interessen: F.\u00a0Roll gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter An\u00e4sthesist, Asklepios Klinik Wandsbek, Hamburg | Mitgliedschaft: DGAI.\n                      J.\u00a0Koscielny\n                      : A.\u00a0Finanzielle Interessen: Referent f\u00fcr Aspen, Bayer Health Care Pharmaceuticals, Daiichi Sankyo, BioMarin, Boehringer Ingelheim, CSL Behring, Pfizer, LFB, BMS, Mitsubishi, Roche, Sanofi, Novo Nordisk, Chugai, Octapharma.\u00a0\u2013 Berater f\u00fcr CSL Behring, BioMarin, Pfizer bzgl. Gentherapie in der H\u00e4mophilie. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Leiter der Gerinnungsambulanz mit H\u00e4mophiliezentrum am CCM (Campus Charit\u00e9 Mitte) | im AGZ (Ambulanten Gesundheitszentrum) der Charit\u00e9 | 1.\u00a0Vorsitzender des BDDH (Berufsverband der Deutschen H\u00e4mostaseologen)\n                      \n                      ; Mitglied des DHR-Fachausschuss (PEI)\n                      \n                      ; Mitglied des Arbeitskreis Blut (BMG-RKI)\n                      \n                      ; Co-Chair 2017, Berlin, ISTH (Weltkongress) (\u201eInternational Society of Thrombosis and Haemostasis\u201c); Tagungspr\u00e4sident 2019, Berlin, GTH (Jahreskongress) | (\u201eDeutsche Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaserforschung\u201c); Herausgeber der Zeitschrift:\n                      Vascular Care\u00a0\u2013 Niedermolekulare Heparine im Trend\n                      . ISSN: 1615-6080. Socio-medico Verlag (SMV); Board-Autor des\n                      Pschyrembel\n                      . Kapitel: Gerinnungsst\u00f6rungen. in:\n                      Pschyrembel \u2013\u00a0Klinisches W\u00f6rterbuch\n                      seit der 262.\u00a0Auflage.\n                      M.-L.\u00a0Lindner\n                      : A.\u00a0Finanzielle Interessen: M.-L.\u00a0Lindner gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte an\u00e4sthesiologische Ober\u00e4rztin in der Asklepios Klinik Wandsbek, Hamburg. Mitgliedschaften: DGAI, AGNN.\u00a0\n                      K.\u00a0Zacharowski\n                      : A.\u00a0Finanzielle Interessen: The Department of Anaesthesiology, Intensive Care Medicine & Pain Therapy of the University Hospital Frankfurt, Goethe University received support from B.\u00a0Braun Melsungen, Melsungen (Germany), CSL Behring, Hattersheim (Germany), Fresenius Kabi, Bad Homburg (Germany), and Vifor Pharma, Munich (Germany) for the implementation of Frankfurt\u2019s Patient Blood Management program. \u2013\u00a0K.Z. has received honoraria for participation in advisory board meetings for Haemonetics, Boston (USA) and Vifor, Munich (Germany) and received speaker fees from CSL Behring, Hattersheim (Germany), Masimo, Irvine (USA), Pharmacosmos, Copenhagen (Denmark), Boston Scientific, D\u00fcsseldorf (Germany), Salus, Bruckm\u00fchl (Germany), iSEP, Nantes (France), Edwards, Munich (Germany), Hemosonics, Asni\u00e8res-sur-Seine (France), Baxter Deutschland GmbH (Germany) and GE Healthcare, D\u00fcsseldorf (Germany). He is the Principal Investigator of the EU-Horizon 2020 project ENVISION (Intelligent plug-and-play digital tool for real-time surveillance of COVID-19\u00a0patients and smart decision-making in Intensive Care Units) and Horizon Europe 2021 project COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19). Partner for EU Horizon 2023 project EDiHTA. | K.Z. leads as CEO the Christoph Lohfert Foundation, Hamburg (Germany) as as well as the Health, Patient Safety & PBM Foundation, Bad Homburg (Germany).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Direktor, Klinik f\u00fcr An\u00e4sthesiologie, Intensivmedizin und Schmerztherapie, Universit\u00e4tsklinikum Frankfurt, Goethe Universit\u00e4t, Theodor-Stern-Kai 7, 60590 Frankfurt am Main | Ambassador & Past-President European Society of Anaesthesiology & Intensive Care.","order":2,"name":"Ethics","label":"Autorinnen und Autoren","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":3,"name":"Ethics","label":"Wissenschaftliche Leitung","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","label":"Der Verlag","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}